Best Practice & Research Clinical Anaesthesiology
Volume 20, Issue 1 , Pages 69-79 , March 2006

Special cases: Ketamine, nitrous oxide and xenon

References 

  1. Vanluchene AL, Vereecke H, Thas O, et al. Spectral entropy as an electroencephalographic measure of anesthetic drug effect: a comparison with bispectral index and processed midlatency auditory evoked response. Anesthesiology. 2004;101:34–42
  2. Kreuer S, Biedler A, Larsen R, et al. Narcotrend monitoring allows faster emergence and a reduction of drug consumption in propofol-remifentanil anesthesia. Anesthesiology. 2003;99:34–41
  3. Kubota K, Hirota K, Yoshida H, et al. Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats — GABAA receptor activator vs NMDA receptor inhibitor. Psychopharmacology. 1999;146:335–338
  4. Kubota K, Hirota K, Anzawa N, et al. Physostigmine antagonizes ketamine-induced noradrenaline release from the medial prefrontal cortex in rats. Brain Research. 1999;840:175–178
  5. Yoshida H, Kushikata T, Kubota T, et al. Increased norepinephrine release from anterior and posterior hypothalamus following xenon inhalation. Canadian Journal of Anesthesia. 2001;48:651–655
  6. Kushikata T, Hirota K, Yoshida H, et al. Alpha-2 adrenoceptor activity affects propofol-induced sleep time. Anesthesia & Analgesia. 2002;94:1201–1206
  7. Dazzi L, Sanna A, Cagetti E, et al. Inhibition by the neurosteroid allopregnanolone of basal and stress-induced acetylcholine release in the brain of freely moving rats. Brain Research. 1996;710:275–280
  8. Shichino T, Murakawa M, Adachi T, et al. Effects of xenon on acetylcholine release in the rat cerebral cortex in vivo. British Journal of Anaesthesia. 2002;88:866–868
  9. Shichino T, Murakawa M, Adachi T, et al. Effects of inhalation anaesthetics on the release of acetylcholine in the rat cerebral cortex in vivo. British Journal of Anaesthesia. 1998;80:365–370
  10. Kikuchi T, Wang Y, Sato K, Okumura F. In vivo effects of propofol on acetylcholine release from the frontal cortex, hippocampus and striatum studied by intracerebral microdialysis in freely moving rats. British Journal of Anaesthesia. 1998;80:644–648
  11. Kikuchi T, Wang Y, Shinbori H, et al. Effects of ketamine and pentobarbitone on acetylcholine release from the rat frontal cortex in vivo. British Journal of Anaesthesia. 1997;79:128–130
  12. Saint-Mleux B, Eggermann E, Bisetti A, et al. Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area. Journal of Neuroscience. 2004;24:63–67
  13. Shouse MN, Staba RJ, Ko PY, et al. Monoamines and seizures: microdialysis findings in locus coeruleus and amygdala before and during amygdala kindling. Brain Research. 2001;892:176–192
  14. Tonduli LS, Testylier G, Masqueliez C, et al. Effects of huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology. 2001;22:29–37
  15. Ebert TJ, Kampine JP. Nitrous oxide augments sympathetic outflow: direct evidence from human peroneal nerve recordings. Anesthesia & Analgesia. 1989;69:444–449
  16. Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. British Journal of Anaesthesia. 1996;77:441–444
  17. Ishiguro Y, Goto T, Nakata Y, et al. Effect of xenon on autonomic cardiovascular control—comparison with isoflurane and nitrous oxide. Journal of Clinical Anesthesia. 2000;12:196–201
  18. Patel PM, Drumond JC. Cerebral physiology and the effects of anesthetics and techniques. In:  Miller RD editors. Anesthesia. 6th edn. New York: Churchill-Livingstone; 2005;p. 813–857
  19. Takeshita H, Okuda Y, Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology. 1972;36:69–75
  20. Holcomb HH, Lahti AC, Medoff DR, et al. Sequential regional cerebral blood flow brain scans using PET with H215O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology. 2001;25:165–172
  21. Långsjö JW, Kaisti KK, Aalto S, et al. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003;99:614–623
  22. Långsjö JW, Salmi E, Kaisti KK, et al. Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. Anesthesiology. 2004;100:1065–1071
  23. Pfenninger EG, Durieux ME, Himmelseher S. Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers. Anesthesiology. 2002;96:357–366
  24. Zsigmond EK, Kelsch RC, Kothary SP. Rise in plasma free-norepinephrine during anesthetic induction with ketamine. Behavioral Neuropsychiatry. 1974–1975;6:81–84
  25. Breier A, Malhotra AK, Pinals DA, et al. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. American Journal of Psychiatry. 1997;154:805–811
  26. Strebel S, Kaufmann M, Maitre L, Schaefer HG. Effects of ketamine on cerebral blood flow velocity in humans. Influence of pretreatment with midazolam or esmolol. Anaesthesia. 1995;50:223–228
  27. Sakai K, Cho S, Fukusaki M, et al. The effects of propofol with and without ketamine on human cerebral blood flow velocity and CO2 response. Anesthesia & Analgesia. 2000;90:377–382
  28. Eintrei C, Sokoloff L, Smith CB. Effects of diazepam and ketamine administered individually or in combination on regional rates of glucose utilization in rat brain. British Journal of Anaesthesia. 1999;82:596–602
  29. Kumar SM, Kothary SP, Zsigmond EK. Plasma free norepinephrine and epinephrine concentrations following diazepam-ketamine induction in patients undergoing cardiac surgery. Acta Anaesthesiologica Scandinavica. 1978;22:593–600
  30. Reinstrup P, Ryding E, Algotsson L, et al. Effects of nitrous oxide on human regional cerebral blood flow and isolated pial arteries. Anesthesiology. 1994;81:396–402
  31. Matta BF, Lam AM. Nitrous oxide increases cerebral blood flow velocity during pharmacologically induced EEG silence in humans. Journal of Neurosurgical Anesthesiology. 1995;7:89–93
  32. Hormann C, Schmidauer C, Kolbitsch C, et al. Effects of normo- and hypocapnic nitrous-oxide-inhalation on cerebral blood flow velocity in patients with brain tumors. Journal of Neurosurgical Anesthesiology. 1997;9:141–145
  33. Eng C, Lam AM, Mayberg TS, et al. The influence of propofol with and without nitrous oxide on cerebral blood flow velocity and CO2 reactivity in humans. Anesthesiology. 1992;77:872–879
  34. Knudsen L, Cold GE, Holdgard HO, et al. The effects of midazolam on cerebral blood flow and oxygen consumption, interaction with nitrous oxide in patients undergoing craniotomy for supratentorial cerebral tumours. Anaesthesia. 1990;45:1016–1019
  35. Fink H, Blobner M, Bogdanski R, et al. Effects of xenon on cerebral blood flow and autoregulation: an experimental study in pigs. British Journal of Anaesthesia. 2000;84:221–225
  36. Schmidt M, Marx T, Kotzerke J, et al. Cerebral and regional organ perfusion in pigs during xenon anaesthesia. Anaesthesia. 2001;56:1154–1159
  37. Schmidt M, Marx T, Papp-Jambor C, et al. Effect of xenon on cerebral autoregulation in pigs. Anaesthesia. 2002;57:960–966
  38. Yao LP, Bandres J, Nemoto EM, et al. Effect of 33% xenon inhalation on whole-brain blood flow and metabolism in awake and fentanyl-anesthetized monkeys. Stroke. 1992;23:69–74
  39. Whitehurst SL, Nemoto EM, Yao L, Yonas H. MAC of xenon and halothane in rhesus monkeys. Journal of Neurosurgical Anesthesiology. 1994;6:275–279
  40. Plougmann J, Astrup J, Pedersen J, Gyldensted C. Effect of stable xenon inhalation on intracranial pressure during measurement of cerebral blood flow in head injury. Journal of Neurosurgery. 1994;81:822–888
  41. Rosén I, Hägerdal M. Electroencephalographic study of children during ketamine anesthesia. Acta Anaesthesiologica Scandinavica. 1976;20:32–39
  42. White PF, Schuttler J, Shafer A, et al. Comparative pharmacology of the ketamine isomers. Studies in volunteers. British Journal of Anaesthesia. 1985;57:197–203
  43. Yamamura T, Fukuda M, Takeya H, et al. Fast oscillatory EEG activity induced by analgesic concentrations of nitrous oxide in man. Anesthesia & Analgesia. 1981;60:283–288
  44. Ramsay DS, Leroux BG, Rothen M, et al. Nitrous oxide analgesia in humans: acute and chronic tolerance. Pain. 2005;114:19–28
  45. Avramov MN, Shingu K, Mori K. Progressive changes in electroencephalographic responses to nitrous oxide in humans: a possible acute drug tolerance. Anesthesia & Analgesia. 1990;70:369–374
  46. Morris LE, Knott JR, Pittinger CB. Electro-encepharographic and blood gas observation in human surgical patients during xenon anesthesia. Anesthsiology. 1955;16:312–319
  47. Hirota K, Kubota T, Ishihara H, Matsuki A. The effects of nitrous oxide and ketamine on the bispectral index and 95% spectral edge frequency during propofol-fentanyl anaesthesia. European Journal of Anaesthesiology. 1999;16:779–783
  48. Hemmerling TM, Olivier JF, Basile F, et al. Bispectral index as an indicator of cerebral hypoperfusion during off-pump coronary artery bypass grafting. Anesthesia & Analgesia. 2005;100:354–356
  49. Hayashida M, Chinzei M, Komatsu K, et al. Detection of cerebral hypoperfusion with bispectral index during paediatric cardiac surgery. British Journal of Anaesthesia. 2003;90:694–698
  50. Umegaki N, Hirota K, Kitayama M, et al. A marked decrease in bispectral index with elevation of suppression ratio by cervical haematoma reducing cerebral perfusion pressure. Journal of Clinical Neuroscience. 2003;10:694–696
  51. Rampil IJ, Kim JS, Lenhardt R, et al. Bispectral EEG index during nitrous oxide administration. Anesthesiology. 1998;89:671–677
  52. Puri GD. Paradoxical changes in bispectral index during nitrous oxide administration. British Journal of Anaesthesia. 2001;86:141–142
  53. Goto T, Nakata Y, Saito H, et al. Bispectral analysis of the electroencephalogram does not predict responsiveness to verbal command in patients emerging from xenon anaesthesia. British Journal of Anaesthesia. 2000;85:359–363
  54. Schwender D, Faber-Zullig E, Fett W, et al. Mid-latency auditory evoked potentials in humans during anesthesia with S(+) ketamine — a double-blind, randomized comparison with racemic ketamine. Anesthesia & Analgesia. 1994;78:267–274
  55. Schwender D, Klasing S, Madler C, et al. Mid-latency auditory evoked potentials during ketamine anaesthesia in humans. British Journal of Anaesthesia. 1993;71:629–632
  56. Vereecke HE, Struys MM, Mortier EP. A comparison of bispectral index and ARX-derived auditory evoked potential index in measuring the clinical interaction between ketamine and propofol anaesthesia. Anaesthesia. 2003;58:957–961
  57. Plourde G, Baribeau J, Bonhomme V. Ketamine increases the amplitude of the 40-Hz auditory steady-state response in humans. British Journal of Anaesthesia. 1997;78:524–529
  58. Goto T, Nakata Y, Saito H, et al. The midlatency auditory evoked potentials predict responsiveness to verbal commands in patients emerging from anesthesia with xenon, isoflurane, and sevoflurane but not with nitrous oxide. Anesthesiology. 2001;94:782–789
  59. Barr G, Anderson R, Jakobsson J. The effects of nitrous oxide on the auditory evoked potential index during sevoflurane anaesthesia. Anaesthesia. 2002;57:736–739

PII: S1521-6896(05)00071-6

doi: 10.1016/j.bpa.2005.08.014

Best Practice & Research Clinical Anaesthesiology
Volume 20, Issue 1 , Pages 69-79 , March 2006

Article Tools

* Image Usage & Resolution